Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co., Ltd./ US6827361030 /
OPHLY
|
2024-05-03 9:47:51 PM
|
Chg.
+0.0300
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
4.9600USD
|
+0.61%
|
70,182
Turnover: 341,371.4179 |
-Bid Size: - |
-Ask Size: - |
10.89 bill.USD |
- |
- |
Fundamentals
| |
FY 2021 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
162.19 JPY |
- |
| EPS Diluted: |
- JPY |
- |
| Revenues per Share: |
- JPY |
- |
| Book Value per Share: |
- JPY |
- |
| Cash Flow per Share: |
- JPY |
- |
| Dividend per Share: |
- JPY |
- |
| Total |
in mill. |
|
| Revenues: |
361,361.00 JPY |
- |
| Net Income: |
80,519.00 JPY |
- |
| Operating Cash Flow: |
61,829.00 JPY |
- |
| Cash and Cash Equivalents: |
69,112.00 JPY |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
- |
- |
| P/BV ratio: |
- |
- |
| P/CF Ratio: |
- |
- |
| PEG: |
- |
- |
| Earnings Yield: |
- |
- |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
10.89 bill. USD |
0.0000 USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
- |
|
Profitability
| Gross Profit Margin: |
74.12% |
| EBIT Margin: |
28.56% |
| Net Profit Margin: |
22.28% |
| Return on Equity: |
12.28% |
| Return on Assets: |
10.89% |
Financial Strength
| Liquidity I / Cash Ratio: |
104.83% |
| Liquidity II / Quick Ratio: |
256.20% |
| Liquidity III / Current Ratio: |
426.64% |
| Debt / Equity Ratio: |
12.70% |
| Dynam. Debt / Equity Ratio: |
134.72% |
Efficiency
| Employees: |
3,687 |
| Personal Expenses / Employee: |
- JPY |
| Revenues / Employee: |
98,009,492.81 JPY |
| Net Income / Employee: |
21,838,622.19 JPY |
| Total Assets / Employee: |
200,489,015.46 JPY |
| * Fiscal Year End: |
2022-03-31 |
| Accounting Standard: |
IFRS |
